ACE2 and COVID-19: In this study we further demonstrate the increased ACE2 expression in bronchial biopsies from subjects with cardiovascular disease and hypertension, highlighting a potential mechanism impacting the widely reported increased susceptibility to COVID-19 in these patients [5].